Bilateralna totalna artroplastika kukova u jednom aktu – desetogodišnje iskustvo

  • Aleksandar Radunović Military Medical Academy, Clinic for Orthopedic Surgery and Trumatology, Belgrade, Serbia
  • Vesna Radunović Pharmacy Belgrade, Belgrade, Serbia
  • Srdjan Starčević Military Medical Academy, Clinic for Orthopedic Surgery and Trumatology, Belgrade, Serbia
  • Goran Lekić Military Medical Academy, Clinic for Orthopedic Surgery and Trumatology, Belgrade, Serbia
  • Maja Vulović University of Kragujevac, Faculty of Medical Sciences, Department of Anatomy and Forensic Medicine, Kragujevac, Serbia
Ključne reči: artroplastika kuka, hirurgija, operativne procedre, komorbiditet, postoperativne komplikacije, srbija

Sažetak


Uvod/ Cilj. Koksartroza je hronično degenerativno oboljenje koje se javlja kod oko 4% populacije, a procenjuje se da oko 42% bolesnika ima bilateralno oboljenje. Bolesnicima sa bilateralnom koksartrozom može se učiniti artroplastika oba kuka u jednom ili dva akta. Cilj ovog rada bio je prezentacija našeg iskustva sa izvođenjem simultane bilateralne artroplastike kukova i preporuka za izvođenje procedure kod bolesnika sa adekvatnom indikacijom. Metode. Obradili smo podatke za 113 bolesnika oba pola koji su operisani na Klinici za ortopedsku hirurgiju i traumatologiju Vojnomedicinske akademije u Beogradu, Srbija, u periodu od 2005. do 2015. godine, a kojima je učinjena artroplastika oba kuka u jednom aktu. Kod svih bolesnika je primenjena identična operativna tehnika uz identičnu standardnu antibiotsku i tromboprofilaktičku terapiju. Postoperativno praćenje bolesnika je iznosilo 30 dana. Rezultati. Prosečna starost bolesnika bila je 56 ± 10.2 godina; muškog pola je bilo 45 (39,8%), a ženskog pola 68 (60,2%) bolesnika. Primarna koksartroza je bila etiološki faktor kod većine bolesnika, njih 69 (61,1%). Prosečna dužina hospitalizacije postoperativno bila je 10,3 dana (od 3 do 34 dana). Zabeležili smo sledeće komplikacije: jedna luksacija endoproteze, jedna duboka infekcija i jedna tromboza vena noge. Nije bilo smrtnih slučajeva. Najveći broj operisanih bolesnika pripadao je grupama American Society of Anesthesiologists (ASA) skoring sistema 1-3. Prosečna količina transfuzionisane krvi iznosila je 1 275 mL (od 300 do 2 830 mL). Zaključak. Bilateralna artroplastika kukova u jednom aktu može se izvoditi rutinski i bezbedno u ustanovama koje omogućavaju multidisciplinarni pristup i adekvatnu selekciju bolesnika. Podaci iz naše studije ukazuju na povećanu potrebu za supstitucijom krvi što naglašava potrebu za uvođenjem savremenih principa perioperativne kontrole gubitka krvi. Uče­stalost komplikacija zabeleženih u ovoj studiji je u okviru stepena učestalosti saopštenih u literaturi koja se bavi artroplastikama kukova.

Reference

Allen K, Golightly Y. State of the evidence. Curr Opin Rheu-matol 2015; 27(3): 276-283.

Aghayev E, Beck A, Staub L, Dietrich D, Melloh M, Orljanski W, at al. Simultaneous bilateral hip replacement reveals superior outcome and fewer complications than two- stage procedures: a prospective study including 1819 patients and 5801 follow-ups from a total joint replacement registry. BMC Musculo-skelet Disord 2010; 11: 245.

Stavrakis AI, SooHoo NF, Lieberman JR. Bilateral Total Hip Ar-throplasty has Similar Complication Rates to Unilateral Total Hip Arthroplasty. J Arthroplasty 2015; 30(7): 1211–4.

Garland A, Rolfson O, Garellick G, Kärrholm J, Hailer N. Early postoperative mortality after simultaneous or staged bilateral primary total hip arthroplasty: an observational register study from the swedish Hip arthroplasty register. BMC Musculo-skelet Disord 2015; 16: 77.

Trojani C, d’Ollone T, Saragaglia D, Vielpeau C, Carles M, Pru-dhon JL. One stage bilateral total hip arthroplasty: Functional outcome and complications in 112 patients Orthop Traumatol Surg Res 2012; 98(6): S120–3.

Namba RS, Inacio MC, Paxton EW. Risk factors associated with surgical site infection in 30 491 primary total hip replace-ments. J Bone Joint Surg Br 2012; 94(10): 1330–8.

Berend ME, Ritter MA, Harty LD, Davis KE, Keating EM, Meding JB, at al. Simultaneous bilateral versus unilateral total hip arthroplasty. J Arthroplasty 2005; 20(4): 421–6.

Berend KR, Lombardi AV Jr, Adams JB. Simultaneous vs staged cementless bilateral total hip arthroplasty: perioperative risk comparison. J Arthroplasty 2007; 22(6 Suppl 2): 111–5.

Yeager AM, Ruel AV, Westrich GH. Are bilateral total joint ar-throplasty patients at a higher risk of developing pulmonary embolism following total hip and knee surgery? J Arthroplasty 2014; 29(5): 900–2.

Rasouli MR, Maltenfort MG, Ross D, Hozack WJ, Memtsoudis SG, Parvizi J. Perioperative morbidity and mortality following bilateral total hip arthroplasty. J Arthroplasty 2014; 29(1): 142–8.

Glait SA, Khatib ON, Bansal A, Hochfelder JP, Slover JD. Com-paring the incidence and clinical data for simultaneous bilat-eral versus unilateral total hip arthroplasty in NewYork State between 1990 and 2010. J Arthroplasty 2015; 30(11): 1887–91.

Popović Z, Rajović J, Radunović A. Total bilateral hip arthroplasty in one surgical procedure. Vojnosanit Pregl 2007; 64(10): 697–700. (Serbian)

Lamo-Espinosa J, Troncoso S, Valentí-Azcárate A, Díaz de Rada P, Valentí-Nín JR. Clinical and radiological short-term complica-tions after single stage bilateral uncemented total hip arthro-plasty. Musculoskelet Surg 2015; 99(1): 67–73.

Romagnoli S, Zacchetti S, Perazzo P, Verde F, Banfi G, Viganò M. Simultaneous bilateral total hip arthroplasties do not lead to higher complication or allogeneic transfusion rates compared to unilateral procedures. Int Orthop 2013; 37(11): 2125–30.

Reuben JD, Meyers SJ, Cox DD, Elliott M, Watson M, Shim SD. Cost comparison between bilateral simultaneous, staged, and unilateral total joint arthroplasty. J Arthroplasty 1998; 13(2): 172–9.

Wykman A., Olsson E. Walking ability after total hip arthro-plasty: a comparison of gait analysis in unilateral and bilateral cases. J Bone Joint Surg Br 1992; 74(1): 53–6.

Lazansky M. A Study of Bilateral LowFriction Arthroplasty. Internal Publication No. 3. Appley Bridge, UK: Centre for Hip Surgery, Wrightington Hospital; 1967.

Jaffe WL, Charnley J. Bilateral Charnley low-friction arthro-plasty as a single operative procedure. A report of fifty cases. Bull Hosp Joint Dis 1971; 32(2): 198–214.

Macaulay W, Salvati EA, Sculco TP, Pellicci PM. Single-stage bi-lateral total hip arthroplasty. J Am Acad Orthop Surg 2002; 10(3): 217–21.

Parvizi J, Tarity TD, Sheikh E, Sharkey PF, Hozack WJ, Rothman RH. Bilateral total hip arthroplasty: one-stage versus two-stage procedures. Clin Orthop Relat Res 2006; 453: 137–41.

Bhan S, Pankaj A, Malhotra R. One- or two-stage bilateral to-tal hip arthroplasty: a prospective, randomised, controlled study in an Asian population. J Bone Joint Surg Br 2006; 88(3): 298–303.

Samama CM, Ravaud P, Parent F, Barre J, Mertl P, Mismetti P. Epidemiology of venous thromboembolism after lower limb arthroplasty: the FOTO study. J Thromb Haemost 2007; 5(12): 2360–7.

Liu SS, Della Valle AG, Besculides MC, Gaber LK, Memtsoudis SG. Trends in mortality, complications, and demographics for primary hip arthroplasty in the United States. Int Orthop 2009; 33(3): 643–51.

Jaekel DJ, Ong KL, Lau EC, Watson HN, Kurtz SM. Epidemi-ology of total hip and knee arthroplasty infection. In: Springer BD, Parvizi J, editors. Periprosthetic joint infection of the hip and knee. New York: Springer; 2014. pp. 1–14. Chapter 1.

Kurtz SM, Lau E, Schmier J, Ong KL, Zhao K, Parvizi J. Infec-tion burden for hip and knee arthroplasty in the United States. J Arthroplasty 2008; 23(7): 984–91.

Skutek M, Bourne RB, MacDonald SJ. (i) International epidemi-ology of revision THR. Curr Orthop 2006; 20(3): 157–61.

Sanchez-Sotelo J, Berry DJ. Epidemiology of instability after to-tal hip replacement. Orthop Clin North Am 2001; 32(4): 543–52, vii.

Patel PD, Potts A, Froimson MI. The dislocating hip arthroplas-ty: prevention and treatment. J Arthroplasty 2007; 22(4 Suppl 1): 86–90.

Innerhofer P, Walleczek C, Luz G, Hobisch-Hagen P, Benzer A, Stöckl B, et al. Transfusion of buffy coat-depleted blood components and risk of postoperative infection in orthopedic patients. Transfusion 1999; 39(6): 625–32.

Rawn J. The silent risks of blood transfusion. Curr Opin An-aesthesiol 2008; 21(5): 664–8.

Aderinto J, Brenkel IJ. Pre-operative predictors of the require-ment for blood transfusion following total hip replacement. J Bone Joint Surg Br 2004; 86(7): 970–3.

Rosencher N, Kerkkamp HE, Macheras G, Munuera LM, Menichella G, Barton DM, et al. Orthopedic Surgery Transfu-sion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion. 2003; 43(4): 459–69.

Objavljeno
2021/08/04
Rubrika
Originalni članak